The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27075367 |
55 |
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2. |
Bayer Pharma |
26101576 |
12 |
Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2. |
Abbvie |
25406853 |
72 |
Selective inhibitors of protein methyltransferases. |
Icahn School Of Medicine At Mount Sinai |
25746813 |
37 |
SAH derived potent and selective EZH2 inhibitors. |
Pfizer |
25032507 |
43 |
Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8. |
University Of North Carolina At Chapel Hill |
22975593 |
62 |
Oncoepigenomics: making histone lysine methylation count. |
TBA |
17034119 |
24 |
Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis. |
Wyeth Research |
15916422 |
42 |
Protein farnesyltransferase inhibitors exhibit potent antimalarial activity. |
University Of Washington At Seattle |